CHAPEL HILL, N.C.--(BUSINESS WIRE)--Asklepios BioPharmaceutical, Inc. (AskBio) (www.askbio.com) announced the creation of the Chapel Hill Project (www.ChapelHillProject.org), a non-profit organization created to advance the development of cell and gene therapies for orphan diseases through increased scientific collaboration. AskBio formed such organization in response to the scientific community’s request to make its technology accessible to researchers for use in orphan drug development without the payment of any up-front costs.
